2 UK FinTech stocks I’d buy today

The FinTech industry is booming right now. Here, Edward Sheldon highlights two stocks he’d buy to capitalise on the sector’s growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FinTech (financial technology) industry is booming right now. This industry growth is creating some lucrative opportunities for investors.

Here, I’m going to highlight two UK FinTech stocks I’d buy today. I think these are a great way to capitalise on the related boom.

My top UK FinTech stock

One of my top stock picks is Alpha FX (LSE: AFX). It’s an under-the-radar British company offering foreign exchange (FX) hedging services that help businesses reduce currency risks. It also offers a payment processing network for large-scale international payments that enables businesses to send large sums of money globally more efficiently. Its customers include ASOS, Holland & Barrett, and Halfords.

Alpha FX is growing at a phenomenal rate. Between 2017 and 2020, revenue grew from £13.5m to £46.2m. Meanwhile yesterday, the FinTech company said revenues for the first half of 2021 increased a whopping 89% to £34m. As a result of this strong performance, the group expects to exceed its current expectations for the year (which it upgraded in late May). 

The strong growth isn’t the only thing I like about Alpha FX. I also like the fact it’s a very profitable company. Over the last three years, return on capital employed – a key measure of profitability – has averaged 19.5%, which is excellent. Additionally, I like the fact the company is led by founder Morgan Tillbrook. 

There are risks to consider here, of course. One is that the need to transact FX is closely linked to global trading activity. If economic conditions deteriorate, Alpha could be impacted. Another is the valuation. The company currently trades on a forward-looking P/E ratio of about 37, which is quite high. If growth slows, the stock could take a hit.

Overall however, I think this UK FinTech stock has a lot of appeal.

Data is the new oil

Another sector-related stock I’m bullish on is Experian (LSE: EXPN). It’s a leading provider of credit data and data analytics. Its solutions help businesses make faster, smarter lending decisions.

Experian appears to have considerable momentum right now. In May, the company said it was off to a “strong start” in FY2022 and that it was confident it would have another successful year.

Meanwhile today, Experian has posted revenue growth of 31% for the quarter ended 30 June. As a result of this performance, the company has upgraded its full-year guidance. It now expects to achieve total revenue growth for the year of 13-15% (including organic growth of 9-11%). Before today, analysts had been expecting revenue to climb 11% this year.

One risk here is the valuation. Experian currently trades at 35 times earnings, which doesn’t leave a huge margin of safety. If growth stalls, the shares could fall. Another risk to consider is industry disruption. In the US, the Biden administration wants to create a public credit reporting agency. If this goes ahead, it could hurt Experian’s revenues.

I’m comfortable with the risks however. I think this UK FinTech stock offers an attractive risk/reward proposition.

Edward Sheldon owns shares of ASOS, Alpha FX, and Experian. The Motley Fool UK has recommended ASOS, Alpha FX, and Experian. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »